Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds

We report the main conclusions of the first Chemoinformatics and Artificial Intelligence Colloquium, Mexico City, June 15-17, 2022. Fifteen lectures were presented during a virtual public event with speakers from industry, academia, and non-for-profit organizations. Twelve hundred and ninety students and academics from more than 60 countries. During the meeting, applications, challenges, and opportunities in drug discovery, de novo drug design, ADME-Tox (absorption, distribution, metabolism, excretion and toxicity) property predictions, organic chemistry, peptides, and antibiotic resistance were discussed.

Automated summary

The main conclusions of the first Chemoinformatics and Artificial Intelligence Colloquium include discussions on applications, challenges, and opportunities in drug discovery, de novo drug design, ADME-Tox property predictions, organic chemistry, peptides, and antibiotic resistance. The event attracted speakers from industry, academia, and non-for-profit organizations, as well as 1290 students and academics from over 60 countries.